21 Apr
2019

Qualcomm and Apple settle; Ericsson investigated in China; familiar 101 reform problems; new IV alliance; patent problems for life sciences Nobel laureate; and much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

MONDAY 15th April

A surprise inspection at Ericsson’s Beijing office has set the stage for the first big patent licensing probe by China’s new anti-trust super-regulator. Read more here

From the importance of bringing Nokia on board to the prospects of further agreements, what you need to know about the news of Avanci’s breakthrough deals with Audi and Porsche. Read more here

TUESDAY 16th April

A six year licence agreement with Apple, plus a chipset supply deal and payment from iPhone maker send Qualcomm’s shares soaring after settlement announced. Read more here

Recent assignments showcase different ways Huawei reaps value from patent deals: one sealing its settlement with Samsung, another arming the US’s most prolific NPE. Read more here

As blockchain technology attracts increasing interest, the European Patent Office and China’s National IP Administration are developing different ways of handling applications that read on it. Read more here

Intellectual Ventures has entered into an alliance with Desmarais LLC, giving the boutique firm insight into its portfolio and the opportunity to co-develop licensing and litigation programmes. Read more here

WEDNESDAY 17th April

Your final chance to take part in IAM’s benchmarking survey covering a range of subjects including corporate IP management strategy, monetisation, litigation, patent office performance and policy. Read more here

THURSDAY 18th April

Executives at some of China’s leading domestic mobile manufacturers open up about the reasons they believe an anti-trust investigation of Ericsson is merited. Read more here

Lack of IP funds and staff at Kyoto University may have left immunotherapy pioneer and Nobel laureate Tasuku Honjo with a poor deal in an agreement he signed with Ono Pharmaceutical. Read more here

The prize of certainty, the big question over Huawei and the US’s search for a 5G champion comes to an end – the key takeaways from the Qualcomm/Apple settlement. Read more here

FRIDAY 19th April

Toyota is the biggest shareholder in Denso and that makes the parts company and its supply plans for electric vehicles a vital cog in the auto giant’s recently announced open patent pledge. Read more here

Joff Wild

Author | Editor-in-chief

[email protected]

Joff Wild